02/08/2015 18:28:16 Free Membership Login

Bioquell News (LSE:BQE)

05/18/20156:30AMPRNUSRICHARD SNELLER - Form 8.3 - Bioquell Plc
RICHARD SNELLER - Form 8.3 - Bioquell Plc PR Newswire London, May 18 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Full name of discloser: Richard Edgar... More...>>
05/18/20153:50AMALNCBioquell Puts Itself Up For Sale After TRaC Disposal
LONDON (Alliance News) - Bioquell PLC Monday said it is putting itself up for sale, following the sale of its specialist testing unit TRaC Global Ltd for GBP44.5 million earlier this year. The company said that, on the back of its simplified structure following the sale, increased investor interest in the bio-pharmaceutical... More...>>
03/18/20155:19AMALNCBioquell Swings To Loss But Positive On 2015 After TRaC Unit Sale
LONDON (Alliance News) - Bioquell PLC Wednesday posted a swing to a pretax loss for 2014 in what it called "a challenging year" for its core Bio business, but said it has undertaken changes to put it in a strong position to deliver growth in 2015, following news last Thursday it will sell its specialist testing subsidiary... More...>>
03/12/201510:39AMTMFIs Bioquell plc The Perfect Partner For Shire PLC And BTG plc In Your Portfolio?
http://www.fool.co.uk/investing/2015/03/12/is-bioquell-plc-the-perfect-partner-for-shire-plc-and-btg-plc-in-your-portfolio/ More...>>
03/12/20154:12AMALNCBioquell Shares Soar As It Sells TRaC Unit, Pledges To Return Proceeds
LONDON (Alliance News) - Bioquell PLC shares were up by a third early Thursday after the company said it will sell its specialist testing subsidiary TRaC to Element Materials Technology Group Holdings Ltd for GBP44.5 million in cash, and will return most of the proceeds to its shareholders. In a statement, the specialist... More...>>
01/15/20155:41AMALNCBioquell Expecting Slight Revenue Rise But Warns Of Impairment Charge
LONDON (Alliance News) - Bioquell PLC Thursday said it generated slightly more revenue during 2014 compared to the previous year, but warned it will be making a GBP3.9 million impairment charge against patents, products and its wound-care technology following a review of its Bio division. The provider of microbiological... More...>>
11/20/20145:35AMALNCCORRECT (19/11): Bioquell 10-Month Revenue Down But Ebola Work Is Raising Profile
(An item published November 19 misstated the name of a product. The corrected version follows.) LONDON (Alliance News) - Bioquell PLC said Wednesday it saw revenue down 3% in the ten months to the end of October, and noted that the recent outbreak of Ebola in West Africa has increased awareness of its technology. Bioquell... More...>>
11/19/20144:51AMALNCBioquell 10-Month Revenue Down But Ebola Work Is Raising Profile
LONDON (Alliance News) - Bioquell PLC said Wednesday it saw revenue down 3% in the ten months to the end of October, and noted that the recent outbreak of Ebola in West Africa has increased awareness of its technology. Bioquell said its hydrogen peroxide vapour technology was used to decontaminate Ebola patient rooms in... More...>>
09/02/20147:15AMALNCDIRECTOR DEALINGS: Bioquell Chief Executive Buys 15,000 Shares
LONDON (Alliance News) - Bioquell PLC Tuesday said Chief Executive Nick Adams bought 15,000 shares at a price of 95 pence per share. Following this transaction, Adams holds 1 million shares, which represents 2.4% of the company's issued share capital. Shares were trading down 0.5% at 95.00p Tuesday midday. By Arvind Bhunjun;... More...>>
08/26/201410:57AMALNCIN THE KNOW: Investec Raises Bioquell To Add On Cost Savings
LONDON (Alliance News) - Investec has raised Bioquell's rating to Add from Hold, though with a price target cut to 98 pence per share from 133p, as it believes that the company's recent contract wins and enhanced restructuring programme should lead to a recovery in profitability. Bioquell shares are trading down 1.6% at... More...>>
08/26/20145:27AMALNCBioquell On Track For Full-Year Expectations As It Swings To Loss
LONDON (Alliance News) - Bioquell PLC said it was on track to meet its expectations rise for the full-year, as it swung to a pretax loss in the half-year to the end of June as revenue declined, and it saw research, development and engineering costs rise. The healthcare equipment manufacturer and supplier posted a pretax... More...>>

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us lse bqe150802 18:28